SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-13-307934
Filing Date
2013-07-30
Accepted
2013-07-29 19:24:09
Documents
2
Group Members
ARNOLD L. ORONSKYBRUCE A. CLEVELANDDOUGLAS A. PEPPERGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS IX, LLCKHALED A. NASRNINA S. KJELLSONPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13D d573938dsc13d.htm SC 13D 246068
2 EX-99.A d573938dex99a.htm EX-99.A 7744
  Complete submission text file 0001193125-13-307934.txt   255760
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86177 | Film No.: 13993801
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

IRS No.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D